HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Leverages Power Of Digital Personalization With Nicorette UK Extension

Executive Summary

Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.

You may also be interested in...



J&J Nicorette Survey: COVID-19 Drives A Quarter Of UK Smokers To Want To Quit

Research shows more and more UK consumers wanting to quit in the wake of the pandemic. J&J Consumer Health is looking to pharmacy as well as its new Nicorette QuickMist SmartTrack product to support smokers on their post-COVID quitting journey. 

J&J’s Nicorette QuickMist SmartTrack – Getting Inside One Of 2020’s Biggest UK Launches

HBW Insight speaks to Johnson & Johnson's Bill Twomey and Sven Sjovall about how one of the biggest OTC launches of 2020 – Nicorette QuickMist SmartTrack – uses behavioral science techniques to help motivate consumers to quit smoking and overcame COVID-related supply chain difficulties to launch a much-needed digital smoking cessation aid in the middle of a pandemic. 

Rx-To-OTC Switch, Digitalization And CBD High On The Agenda For UK Industry In 2021

The PAGB's Michelle Riddalls tells HBW Insight about the association's hopes for post-Brexit Rx-to-OTC switch, its exciting research into the impact of digitalization on the UK consumer health industry, as well as its intention to look at whether to welcome the country's fast-growing CBD food supplements manufacturers into the fold.

Related Content

Topics

UsernamePublicRestriction

Register

RS150743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel